At a glance

ClinicalIndex Comparison Record

N/ACompleted· 150 enrolled

Drug / intervention

Laparoscopic Hepatectomy +1 moreprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02243384

NCT02243384N/ACompleted

Compare CT.gov

A Randomized Controlled Trial of Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma

ChenJian·interventional·Posted Sep 17, 2014·Updated Jun 2, 2022

In Brief

A clinical study evaluating Laparoscopic Hepatectomy and Radiofrequency Ablation for Hepatocellular Carcinoma. Completed, enrolled 150 participants across 1 site.

Detailed Summary

The purpose of this research is to compare short-term and long-term efficacy of laparoscopic hepatectomy and radiofrequency ablation in the Treatment of early hepatocellular carcinoma, and provide the evidence for the choice of surgical method from the pathology and cytology.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHepatocellular Carcinoma

CountriesChina

Collaborators--

Timeline

N/ACompletedFinished

201520162017201820192020202120222023202420252026

Enrollment StartSep 2014

First PostedSep 2014

Primary CompletionJan 2021

Study CompletionOct 2021

TodayJul 2026

First PostedSep 17, 2014

Enrollment StartSep 1, 2014

Primary CompletionJan 1, 2021

Study CompletionOct 1, 2021

TodayJul 2, 2026

Enrollment to primary: 6.3 yearsPosted 11.8 years ago

Interventions

Laparoscopic Hepatectomyprocedure

A total of 110 patients with early HCC with nodular diameters of less than 3 cm and up to three nodules were randomly divided into LH (n=55) and RFA groups (n=55). Outcomes were carefully monitored and evaluated during the 3-year follow-up period

Radiofrequency Ablationprocedure